NEWS

Share 0
Like 0
LIST OF ACCEPTED SYMPOSIA-SPEAKERS Dopamine 2013

LIST OF ACCEPTED SYMPOSIA-SPEAKERS Dopamine 2013

Dopamine 2013-List of accepted symposia

DOPAMINE 2013

LIST OF ACCEPTED SYMPOSIA-SPEAKERS

TOPICS

1. DOPAMINE NEURONS 

2. ANATOMY AND PHYSIOLOGY OF DOPAMINE SYSTEMS 

3. DOPAMINE RECEPTORS 

4. DOPAMINE COTRANSMISSION 

5. DOPAMINE AND SIGNAL TRANSDUCTION 

6. DOPAMINE AND NEUROPLASTICITY 

7. IMAGING DOPAMINE 

8. DOPAMINE AND REWARD 

9. DOPAMINE AND ADDICTION 

10.DOPAMINE AND COGNITION 

11.DOPAMINE AND AFFECTIVE DISORDERS 

12.DOPAMINE AND NEURODEGENERATION 

13.DOPAMINE AND PARKINSON’S DISEASE 

14.DOPAMINE AND SCHIZOPHRENIA.

 

DOPAMINE NEURONS

1st SYMPOSIUM

TOPIC-DOPAMINE NEURON

TITLE

REGULATION OF VTA DA NEURONS BY

OREXIN/HYPOCRETIN: MECHANISMS, CIRCUITS AND

BEHAVIORS

 

ORGANIZER: ASTON-JONES GARY

Medical University of south Carolina Neurosciences – USA

1st SPEAKER BORGLAND STEPHANIE

Univ. of British Columbia-Anesthesiology, pharmacology & Therapeutics -CANADA

2nd SPEAKER STEVE MAHLER

Medical University of south Carolina-Neurosciences -USA

3rd SPEAKER DAYAS CHRISTOPHER

University of Newcastle Anatomy - AUSTRALIA

4th SPEAKER ESPANA RODRIGO

Drexel university College of medicine Neurobiology and anatomy – USA

5th SPEAKER MCNALLY GAVAN

University of New South Wales-Psychology - AUSTRALIA

2nd SYMPOSIUM

TOPIC-DOPAMINE NEURON

 

TITLE

NEUROENDOCRINE DOPAMINE NEURONS:

PHYSIOLOGY, REGULATION AND CLINICAL ROLE

 

ORGANIZER: BROBERGER CHRISTIAN

Karolinska Institutet, Dept. of Neuroscience –SWEDEN

1st SPEAKER HOLT RICHARD

University of Southampton Developmental Origins of Adult Health

and Disease Division –UNITED KINGDOM

2nd SPEAKER GRATTAN DAVID

University of Otago Dept. Of Anatomy – NEW ZEALAND

3rd SPEAKER BROBERGER CHRISTIAN

Karolinska Institutet, Dept. of Neuroscience - SWEDEN

4th SPEAKER  MARTIN AGNES

Institut de Genomique Fonctionnelle/Inserm Dept of Endocrinology – FRANCE

5th SPEAKER BERTRAM RICHARD

Florida State University Dept of Mathematics - USA

3rd SYMPOSIUM

TOPIC-DOPAMINE NEURON 

TITLE

THE REGULATION OF DOPAMINE NEURON

ACTIVITY STATES AND ITS RELEVANCE TO

DOPAMINE SYSTEM FUNCTION

 

ORGANIZER GRACE A. ANTHONY

University of Pittsburgh Neuroscience –USA

1st SPEAKER GRACE A. ANTHONY

University of Pittsburgh Neuroscience – USA

2nd SPEAKER MERCURI NICOLA

University of Rome Tor Vergata Neurology – ITALY

3rd SPEAKER ROEPER JOCHEN

Goethe University Frankfurt Neuroscience Center – GERMANY

4th SPEAKER SCHULTZ WOLFRAM

University Cambridge Physiology, Development & Neuroscience - UK

4th SYMPOSIUM

TOPIC-DOPAMINE NEURON 

TITLE

IMPACT OF NETWORK ACTIVITY ON THE

INTEGRATIVE PROPERTIES OF DOPAMINE NEURONS

IN RESPONSE TO NATURAL REWARDS, DRUGS AND

AVERSIVE EVENTS

ORGANIZER GEORGES FRANCOIS

IINS-Interdisciplinary Institute for Neuroscience CNRS-University of Bordeaux

1st SPEAKER GEORGES FRANCOIS

IINS-Interdisciplinary Institute for Neuroscience CNRS-University of Bordeaux

2nd SPEAKER UNGLESS MARK

MRC CLINICAL Sciences centre Imperial College London

3rd SPEAKER CHAOULOFF FRANCIS

Neurocentr Magendie U-862 INSERM – University of Bordeaux

4th SPEAKER ASTON-JONES GARY

Medical University of South Carolina Neuroscience

5th SYMPOSIUM

TOPIC DOPAMINE NEURON

TITLE

NEATING AND BURSTING: THE JOYFUL NOISE OF

DOPAMINE NEURONS

ORGANIZER SHEPARD PAUL

University of Maryland School of Medicine Psychiatry and pharmacology - USA

1st SPEAKER SEUTIN VINCENT

University of Liege Laboratory of Pharmacology and GIGA

Neuroscience - BELGIUM

2nd SPEAKER LEVITAN EDWIN

University of Pittsburg Depart. Of Pharmacology & Chemical Biology

USA

3rd SPEAKER SHEPARD PAUL

University of Maryland School of Medicine Psychiatry and pharmacology - USA

4th SPEAKER CANAVIER CARMEN

Louisiana State University Health Sciences Center Department of Cell Biology and Anatomy - USa

6th SYMPOSIUM

TOPIC DOPAMINE NEURON

TITLE

IS OUR LIFE STYLE KILLING OUR DOPAMINE NEURONS?

ORGANIZER ZIGMOND MICHAEL

University of Pittsburg Neurology, USA

1st SPEAKER HOFFER J. BARRY

Case Western Reserve University School of Medicine Neurosurgery

2nd SPEAKER CICCHETTI FRANCESCA

University of Laval Centre de Recherche du CHUQ (CHUL)

Neuroscience CANADA

3rd SPEAKER MENDEL A. SYLVIA

Technion-Israel Institute of Technology Molecular Pharmacology, ISRAEL

4th SPEAKER RUSSELL A. VIVIENNE

University of Cape Town Dept of Human Biology, SOUTH AFRICA.

5th SPEAKER CAMERON L. JUDY

University of Pittsburgh Psychiatry, USA

7th SYMPOSIUM

TOPIC DOPAMINE NEURON

TITLE

SEROTONIN-DOPAMINE INTERACTION: NEW OPPORTUNITIES FOR IMPROVED TREATMENTS OF DOPAMINE-RELATED DISORDERS

ORGANIZER KATHRYN CUNNINGHAM

1st SPEAKER KATHRYN CUNNINGHAM

UNIVERSITY OF TEXAS MEDICAL BRANCH, CENTER FOR

ADDICTION, 77555 GALVESTON, USA

2nd SPEAKER JOHN NEUMAIER

UNIVERSITY OF WASHINGTON, HARBORVIEW MEDICAL

CENTER, 98104 SEATTLE, USA

3rd SPEAKER UMBERTO SPAMPINATO

UNIVERSITY OF BORDEAUX2, NEUROCENTRE MAGENDIE

INSERM U 866, 33077 BORDEAUX, FRANCE

4th SPEAKER ADRIAN NEWMAN-TANCREDI

NEUROACT COMMUNICATION, 81100 CASTRES, FRANCE

 

8th SYMPOSIUM

TOPIC ANATOMY AND PHYSIOLOGY OF DOPAMINE SYSTEM

TITLE

NEW MECHANISMS BY WHICH TRACE AMINEASSOCIATED

RECEPTORS MODULATE DOPAMINE NEURON ACTIVITY

ORGANIZER GRANDY K. DAVID

Oregon Health & Science University School of Medicine Physiology and Pharmacology– USA

1st SPEAKER GRANDY K. DAVID

Oregon Health & Science University School of Medicine Physiology and Pharmacology– USA

2nd SPEAKER MILLER M. GREGORY

Harvard University New England Primate Research Center - USA

3rd SPEAKER HOENER C. MARIUS

HOFFMANN- LA ROCHE LTD. Central Nervous System Research - Switzerland

4th SPEAKER GAINETDINOV R.RAUL

Italian Institute of Technology Neuroscience and Brain Technologies - ITALY

9th SYMPOSIUM

TOPIC 

ANATOMY AND PHYSIOLOGY OF

DOPAMINE SYSTEM

TITLE 

LOCAL REGULATION OF STRIATAL DOPAMINE RELEASE

ORGANIZER RICE E. MARGARET

New York University of School of Medicine Physiology and Neuroscience - USA

1st SPEAKER CRAGG J. STEPHANIE

University of Oxford Physiology, anatomy and genetics – UK

2nd SPEAKER PATEL C. JYOTI

New York University of School of Medicine Neurosurgery - USA

3rd SPEAKER WEST R. ANTHONY

Rosalind Franklin University of Medicine and Science Neuroscience -USA

4th SPEAKER RICE E. MARGARET

New York University of School of Medicine Physiology and Neuroscience - USA

10th SYMPOSIUM

TOPIC 

ANATOMY AND PHYSIOLOGY OF

DOPAMINE SYSTEM

TITLE

THALAMOSTRIATAL SYNAPSES - ANOTHER

SUBSTRATE FOR DOPAMINE ACTION

ORGANIZER ARBUTHNOTT WILLIAM GORDON

Okinawa Institute for science and technology

graduate University – JAPAN

1st SPEAKER BOLAM J.PAUL

University of Oxford MRC ANATOMICAL Neuropharmacology Unit -

UK

2nd SPEAKER HALLIDAY GLENDA

University of New South Wales Neuropathology - AUSTRALIA

3rd SPEAKER DING JUN

Harvard medical school stanfors.edu Neurobiology - USA

4th SPEAKER KOBAYASHI KAZUTO

Fukushima Med Univ Dept. Mol Genetics, JAPAN

 

11th SYMPOSIUM

TOPIC DOPAMINE RECEPTORS 

TITLE

DOPAMINE RECEPTORS: NEW CELLULAR

MECHANISMS RELEVANT FOR CSN DISORDERS

ORGANIZER LE FOLL BERNARD

University of Toronto Department of Family and community medicine,

pharmacology, psychiatry and istitute of medical sciences, CANADA

1st SPEAKER COLLO GINETTA

Medical School, University of Brescia Department of Biomedical Science and Biotechnologies and woman Health Center – Camillo Golgi Foundation- ITALY

2nd SPEAKER LE FOLL BERNARD

University of Toronto Department of Family and community medicine,

pharmacology, psychiatry and istitute of medical sciences

3rd SPEAKER RABINER EUGENII

Imanova Imaging Sciences Centre Imaging Applications & CMO- UK

4th SPEAKER BOILEAU ISABELLE

Centre for Addiction and Mental Health Research Imaging Centre - CANADA

5th SPEAKER MERLO PICH EMILIO

Cns Biomarker, neuroscience DTA Pred -SWITZERLAND

12th SYMPOSIUM

TOPIC DOPAMINE RECEPTORS

TITLE

DOPAMINE RECEPTOR HETEROMERIC

COMPLEXES AND THEIR FUNCTION

DOPAMINE RECEPTORS

ORGANIZER GEORGE SUSAN

1st SPEAKER GEORGE SUSAN

University of Toronto Centre for Addiction and Mental Health

Pharmacology - CANADA

2nd SPEAKER FERRE SERGI

National Institute on Drug Abuse IRP Biomedical Research Center

CSN Receptor – Receptor Interactions Unit - USA

3rd SPEAKER FRANCO RAFAEL

Universitad de Barcelona Biochemistry and molecular biology - SPAIN

4th SPEAKER SMITH ROY

The Scripps Research Institute Metabolism and Aging

13th SYMPOSIUM

TOPIC DOPAMINE RECEPTORS

TITLE

MOLECULAR DETERMINANTS OF D2 AND D3

RECEPTOR SELECTIVITY AND EFFICACY

 

ORGANIZER SIBLEY DAVID

NINDS National institutes of Health – USA

1st SPEAKER SIBLEY DAVID

NINDS National institutes of Health – USA

2nd SPEAKER NEWMAN HAUCK AMY

NIDA-IRP NIH- USA

3rd SPEAKER JAVITCH JONATHAN

Columbia University Psychiatry and pharmacology - USA

4th SPEAKER SHI LEI

Weill Cornell Medical College Department of Physiology and Biophysics - USA

14th SYMPOSIUM

TOPIC DOPAMINE CONTRANSMISSION

TITLE

THE MULTILINGUAL NATURE OF DOPAMINE NEURONS

ORGANIZER TRUDEAU LOUIS-ERIC

Univ. de Montreal Pharmacology - CANADA

1st SPEAKER TRUDEAU LOUIS-ERIC

Univ. de Montreal Pharmacology – CANADA

2nd SPEAKER RAYPORT STEPHEN

Columbia University Psychiatry – USA

3rd SPEAKER KOOS TIBOR

Rutgers University Center for Molecular and Behavioral Neuroscience - USA

4th SPEAKER MORALES MARISELA

National Institute of Drug abuse Cellular and molecular Neuroscience Branch – USA

5th SPEAKER WALLEN-MACKENZIE ASA

Uppsala University Neuroscience - SWEDEN

15th SYMPOSIUM

TOPIC DOPAMINE AND SIGNAL TRANSUCTION

TITLE

DOPAMINE SIGNALING IN HEALTH AND DISEASE:

MECHANISMS AND INTERVENTIONS

ORGANIZER FISONE GILBERTO

Karolinska Institutet Dept of Neuroscience – SWEDEN

1st SPEAKER VANHOUTTE PETER

Univ. Pierre et Marie Curie UMRS 952, UMR 7224 - FRANCE

2nd SPEAKER MORATALLA ROSARIO

Instituto Cajal (CSIC) Department of Functional System Neurobiology – SPAIN

3rd SPEAKER FISONE GILBERTO

Karolinska Institutet Dept of Neuroscience – SWEDEN

4th SPEAKER BRAMBILLA RICCARDO

San Raffaele Hospital Institute of Experimental Neurology - ITALY

16th SYMPOSIUM

TOPIC DOPAMINE AND SIGNAL TRANSDUCTION

TITLE 

THE IMPACT OF STEROIDS ON DOPAMINE

NEUROTRANSMISSION

ORGANIZER BORTOLATO MARCO

University of Southern California Pharmacology and Pharm. Sciences - USA

1st SPEAKER DI PAOLO THERESE

University of Laval School of Pharmacy - CANADA

2nd SPEAKER FRYE CHERYL

SUNY Albany Psychology – USA

3rd SPEAKER KAILANTO SANNA

National Institute for Health and Welfare Alcohol Drugs and addiction - FINLAND

4th SPEAKER BORTOLATO MARCO

University of Southern California Pharmacology and Pharm. Sciences - USA

17th SYMPOSIUM

TOPIC DOPAMINE AND SCHIZOPHRENIA

TITLE 

FUNCTIONAL CORRELATES OF DOPAMINE RECEPTOR SIGNALLING

ORGANIZER MISSALE CRISTINA

University of Brescia, Italy

1st SPEAKER SHIGETADA NAKANISHI

Osaka Bioscience Istitute, Japan

2nd SPEAKER CRISTINA MISSALE

University of Brescia - Italy

3rd SPEAKER PETER MC CORMIC

University of Barcelona, Spain

4th SPEAKER MARC G CARON

Duke University, USA

18th SYMPOSIUM

TOPIC DOPAMINE AND NEUROPLASTICITY

TITLE

NEW INSIGHTS INTO THE DEVELOPMENT AND

PLASTICITY OF DOPAMINE CONNECTIVITY

ORGANIZER FLORES CECILIA

McGill University Psychiatry – CANADA

1st SPEAKER HENNY PABLO

Pontificia Universidad Cat.lica de Chile

Anatomy/Medicine – CHILE

2nd SPEAKER PASTERKAMP JEROEN

University Medical Center Utrecht

Neuroscience and Pharmacology – NETHERLANDS

3rd SPEAKER BELLONE CAMILLA

University of Geneva Basic Neuroscience – GENEVA

4th SPEAKER FLORES CECILIA

McGill University Psychiatry - CANADA

19th SYMPOSIUM

TOPIC DOPAMINE AND NEUROPLASTICITY

TITLE 

SYNAPTIC AND BEHAVIORAL PLASTICITY IN THE

MESOCORTICOLIMBIC SYSTEM

ORGANIZER LUSCHER CHRISTIAN

University of Geneva Basic Neurosciences – SWITZERLAND

1st SPEAKER JANAK PATRICIA

UCSF Gallo clinic - USA

2nd SPEAKER LUSCHER CHRISTIAN

University of Geneva Basic Neurosciences – SWITZERLAND

3rd SPEAKER MAMELI MANUEL

University of North Carolina at Chapel Hill

Psychiatry – FRANCE

4th SPEAKER TONINI RAFFAELLA

IIT Genova Neuroscience and Brain Technologies - ITALY

20th SYMPOSIUM

TOPIC DOPAMINE AND NEUROPLASTICITY

TITLE

REWARD LEARNING AND DOPAMINE

ORGANIZER WIGHTMAN MARK ROBERT

University of North Carolina at Chapel Hill Chemistry –USA

 1st SPEAKER MEREDITH GLORIA

Rosalind Franklin University of Medicine and Science College of Pharmacy – USA

2nd SPEAKER KENNY JOHN PAUL

The Scripps Research Institute Molecular Therapeutics – USA

3rd SPEAKER WICKENS R. JEFFERY

OKINAWA Institute of science and Technology

Neurobiology Research Unit – JAPAN

4th SPEAKER WIGHTMAN MARK ROBERT

University of North Carolin a at Chapel Hill Chemistry – USA

21st SYMPOSIUM

TOPIC DOPAMINE AND NEUROPLASTICITY

TITLE 

DOPAMINERGIC IMPACT ON NEUROPLASTICITY AND COGNITION IN ANIMALS AND HUMANS –A TRANSLATIONAL APPROACH

ORGANIZER NITSCHE A. MICHAEL

Georg-August-University – Universit Medicine Clinical Neurophysiology, GERMANY

1st SPEAKER GOTO YUKIORI

McGill University, Department of Psychiatry

2nd SPEAKER OTANI SATORU

INSERM U952/CNRS-UMR7224 University of Paris 6, Physiopathology of CNS diseases

3rd SPEAKER NITSCHE A. MICHAEL

Georg-August-University – Universit Medicine Clinical Neurophysiology, GERMANY

4th SPEAKER COOLS ROSHAN

Radbound University Nijmengen Donders Institute For Brain, Cognition and Behaviour Centre for Cognitive Neuroimaging, NETHERLANDS

22nd SYMPOSIUM

TOPIC DOPAMINE AND NEUROPLASTICITY

TITLE DOPAMINE REGULATION OF STRIATAL PLASTICITY

ORGANIZER BELUJON PAULINE

University of Pittsburg Neuroscience –USA

1st SPEAKER BELUJON PAULINE

University of Pittsburg Neuroscience –USA

2nd SPEAKER MALENKA ROBERT

Stanford University school of medicine Psychiatry and behavioral Sciences- USA

3rd SPEAKER PICCONI BARBARA

Fondazione Santa Lucia IRCCS – ITALY

4th SPEAKER REYNOLDS JOHN

University of Otago Anatomy – NEW ZELAND

23rd SYMPOSIUM

TOPIC IMAGING DOPAMINE

TITLE

IMAGING AND THE ROLE OF DOPAMINE ACROSS

ADDICTIONS : DIFFERENCE AND COMMONALITIES

ORGANIZER MARTINEZ DIANA

Columbia University Psychiatry and Radiology - USA

1st SPEAKER MARTINEZ DIANA

Columbia University Psychiatry and Radiology - USA

2nd SPEAKER FORBES ERIKA

UNIVERSITY OF Pittsburgh Psychiatry - USA

3rd SPEAKER HEINZ ANDREAS

CHARITE'–Universitat medizin Berlin Psychiatry of the Charite'. GERMANY

4th SPEAKER NARENDRAN RAJ

Univ. of Pittsburgh, Psychiatry - USA

24th SYMPOSIUM

TOPIC DOPAMINE AND REWARD 

TITLE

ENDOCANNABINOID /DOPAMINE INTERACTIONS AND

THE PURSUIT OF REWARD

ORGANIZER CHEER F. JOSEPH

University of Maryland School of Medicine Anatomy and Neurobiology – USA

1st SPEAKER MELIS MIRIAM

University of Cagliari, ITALY

2nd SPEAKER LUPICA CARL

NIH, Physiology – USA

3rd SPEAKER VENANCE LAURENT

College de France Center for Interdisciplinary Research in Biology

– FRANCE

4th SPEAKER CHEER F. JOSEPH

University of Maryland School of Medicine

Anatomy and Neurobiology - USA

25th SYMPOSIUM

TOPIC DOPAMINE AND REWARD

TITLE 

OPTOGENETIC PERTURBATION OF DOPAMINE

NEURONAL CIRCUITRY

ORGANIZER STUBER GARRET

University of North Carolina at Chapel Hill Psychiatry and Neuroscience Center – USA

1st SPEAKER NAOSHIGE UCHIDA

HARVARD UNIVERSITY, USA

2nd SPEAKER TYE KAY

Massachusetts Institute of Technology, Department of Brain and Cognitive Sciences – USA

3rd SPEAKER WITTEN ILANA

Princeton University, Psycohology – USA

4th SPEAKER BRITT JONATHAN

National Institute on Drug Abuse Intramural Research Program –USA

5th SPEAKER STUBER GARRET

University of North Carolina at Chapel Hill Psychiatry and Neuroscience Center - USA

26th SYMPOSIUM

TOPIC DOPAMINE AND REWARD 

TITLE

GENETIC AND FUNCTIONAL DISSECTION OF THE

DOPAMINE D2 RECEPTOR IN MOTOR AND REWARD –

MEDIATED BEHAVIORS

ORGANIZER RUBINSTEIN MARCELO

CONICET INGEBI – ARGENTINA

1st SPEAKER ALVAREZ A. VERONICA

National Institutes of Health NIAAA – USA

2nd SPEAKER DE KERCHOVE ALBAN

Univ. Libre de Bruxelles Facult. de Medicine, BELGIUM

3rd SPEAKER LOVINGER DAVID

National Institutes of health NIAAA - USA

4th SPEAKER RUBINSTEIN MARCELO

CONICET INGEBI – ARGENTINA

5th SPEAKER WILLIAMS JOHN

Oregon Health & Science University Vollum Institute - USA

27th SYMPOSIUM

TOPIC DOPAMINE AND REWARD

TITLE

INDIVIDUAL DIFFERENCES IN DOPAMINE

SIGNALING: ROLE IN LEARNING, RISK,

TAKING, AND IMPULSIVITY

ORGANIZER DAGHER ALAIN

MCGILL UNIVERSITY NEUROLOGY – CANADA

1st SPEAKER FRANK MICHAEL

Brown University Cognitive, Linguistic and Psychological Sciences

- USA

2nd SPEAKER GJEDDE ALBERT

University of Copenaghen, Neuroscience- Denmark

3rd SPEAKER EBSTEIN RICHARD

NATIONAL University of Singapore Psychology - SINGAPORE

4th SPEAKER CHEW SOO HONG

NATIONAL University of Singapore Economics - Singapore

5th SPEAKER COX SYLVIA

McGill University, Neurology - Canada

28th SYMPOSIUM

TOPIC DOPAMINE AND REWARD

DOPAMINERGIC INVOLVEMENT IN EFFORT–RELATED ASPECTS OF MOTIVATION

ORGANIZER SALAMONE D. JOHN

University of Connecticut Psychology, USA.

1st SPEAKER ZHUANG XIAOXI

University of Chicago Neurobiology - USA

2nd SPEAKER HAUBER WOLFGANG

University of Stuttgart Psychology - GERMANY

3rd SPEAKER WINSTANLEY CATHARINE

University of British Columbia Psychology, CANADA

4th SPEAKER SALAMONE D. JOHN

University of Connecticut Psychology, USA

5th SPEAKER TREADWAY MICHAEL

Harvard University Mc Lean Hospital - USA

29th SYMPOSIUM

TOPIC DOPAMINE AND REWARD

TITLE

DUAL CONTROL OF DOPAMINE BY D2 AUTORECEPTORS AND DAT: REGULATION, EPISTASIS AND BEHAVIORAL IMPACT

ORGANIZER GNEGY ELAINE MARGARET

University of Michigan Pharmacology -USA

1st SPEAKER BENOIT-MARAND

University of Poitiers INSERM U-1084, FRANCE.

2nd SPEAKER GNEGY ELAINE MARGARET

University of Michigan Pharmacology -USA

3rd SPEAKER BERTOLINO ALESSANDRO

University of Bari – “ALDO MORO” Psychiatry - ITALY

4th SPEAKER SADEE WOLFGANG

Ohio State University Pharmacology - USA

30th SYMPOSIUM

TOPIC DOPAMINE AND REWARD

TITLE

NUCLEUS ACCUMBENS: CORE AND SHELL

SPECIALIZATION IN REWARD FUNCTION?

ORGANIZER WISE A ROY

National Inst. Drug Abuse Intramural Research Program - USA

1st SPEAKER IKEMOTO SATOSHI

National Inst. Drug Abuse Intramural Research Program - USA

2nd SPEAKER WISE A ROY

National Inst. Drug Abuse Intramural Research Program - USA

3rd SPEAKER ARAGONA J BRANDON

University of Michigan Psychology -USA

4th SPEAKER DANI A JOHN

Baylor College of Medicine Neuroscience - USA

5th SPEAKER DI CHIARA GAETANO

Dept. of Biomed. Sci., Univ. of Cagliari, ITALY

31st SYMPOSIUM

TOPIC 

DOPAMINE AND ADDICTION

TITLE

DOPAMINE-MEDIATED REWARD AND REINFORCEMENT IN PRECLINICAL DISEASE MODELS

ORGANIZER KANTAK M. KATHLEEN

Boston University, Psychology – USA

1st SPEAKER LINDA J PORRINO

Wake Forest School of Medicine Physiology and Pharmacology – USA

2nd SPEAKER UNTERWALD M. ELLEN

Temple University School of Medicine Pharmacology anc Center for

Substance Abuse Research – USA

3rd SPEAKER IZENWASSER SARI

Univ Miami Miller School of Medicine Psychiatry & Behavioral Sciences USA

4th SPEAKER KANTAK M. KATHLEEN

Boston University Psychology - USA

32nd SYMPOSIUM

TOPIC DOPAMINE AND ADDICTION

TITLE NEUROPLASTICITY OF CORTICOLIMBIC DOPAMINE

AND GLUTAMATE PATHWAYS IN DRUG ADDICTION

ORGANIZER SEE EUGENE RONALD

Medical University of Sout h Carolina Neurosciences – USA

1st SPEAKER VANDERSCHUREN LOUK

University Medical Center Utrecht Rudolf Magnus Institute of

Neuroscience, The Netherlands.

2nd SPEAKER SPANAGEL RAINER

Central Institute of Mental health Institute of Psychopharmacology

University of Heidelberg- GERMANY

3rd SPEAKER VALJENT EMMANUEL

Institute de Genomique Fonctionnelle Neurobiology - FRANCE

4th SPEAKER FUMAGALLI FABIO

Center of Neuropharmacology, University of Milan – Pharmalcological Sciences- ITALY

5th SPEAKER SEE EUGENE RONALD

Medical University of South Carolina Neurosciences - USA

33rd SYMPOSIUM

TOPIC DOPAMINE AND ADDICTION

TITLE 

ETHANOL - MECHANISMS ALONG THE MESOLIMBIC DOPAMINE SYSTEM

ORGANIZER JERLHAG ELISABETH

Neuroscience an physiology Pharmacology, Gothenburg, SWEDEN

1st SPEAKER JERLHAG ELISABETH

Neuroscience an physiology Pharmacology, Gothenburg, SWEDEN

2nd SPEAKER STEENSLAND PIA

Psychiatry, Karolinska University Hospital Clinical Neuroscience, Stockholm, SWEDEN.

3rd SPEAKER MARC S. BRODIE

University of Illinois at Chicago, USA

4th SPEAKER HITOSHI MORIKAWA

Waggoner Center for Alcohol and Addiction Research University of Texas, USA.

34th SYMPOSIUM

TOPIC DOPAMINE AND ADDICTION

TITLE DA ROLE IN THE ADDICTED BRAIN: FROM

SYNAPSES TO HUMAN BRAIN IMAGING

ORGANIZER BONCI ANTONELLO

NIDA, Intramural Research Program USA

1st SPEAKER RUSSO SCOTT

Mount Sinai School of medicine Fishberg Department of Neuroscience - USA

2nd SPEAKER KOOB GEORGE

THE SCRIPPS RESEARCH INSTITUTE Committee on the Neurobiology of addictive Disorders. La Jolla, USA

3rd SPEAKER VOLKOW NORA

NIDA, National Human Research Institute - USA

4th SPEAKER BONCI ANTONELLO

NIDA, Intramural Research Program USA

5th SPEAKER KALIVAS PETER

Medical University Of South Carolina Department of Neuroscience - USA

35th SYMPOSIUM

TOPIC DOPAMINE AND ADDICTION

TITLE THE DOPAMINE TRANSPORTER: NEW INSIGHTS

INTO PSYCHOSTIMULANT ACTIONS AND THE

RELATIOSHIP TO NEUROPSYCHIATRIC DISORDERS

ORGANIZER GETHER ULRIK

University of Copenaghen Faculty of health and Medical Sciences -DENMARK.

1st SPEAKER YAMAMOTO AI

Columbia University, New York, USA

2nd SPEAKER SUTCLIFFE JAMES

Vanderbilt University, Nashville, USA

3rd SPEAKER AMARA SUSAN

University of Pittsburg School of Medicine

Depart. Of Neurobiology - USA

4th SPEAKER GETHER ULRIK

University of Copenaghen Faculty of Health and Medical Sciences -DENMARK

36th SYMPOSIUM

TOPIC DOPAMINE AND ADDICTION

TITLE 

MODULATION OF DOPAMINE SYSTEM FUNCTION BY

NUCLEAR RECEPTORS: FOCUS ON ADDICTION

ORGANIZER CICCOCIOPPO ROBERTO

University of Camerino School of Pharmacy , Pharmacology Unit – ITALY

1st SPEAKER PIAZZA PERVINCENZO

INSERM Neuro Centre Magendie - FRANCE

2nd SPEAKER GOLDBERG STEVEN

NATIONAL Institute of health NIDA - USA

3rd SPEAKER PISTIS MARCO

University of Cagliari Depart. Of Biomedical Sciences – ITALY

4th SPEAKER CICCOCIOPPO ROBERTO

University of Camerino School of Pharmacy , Pharmacology Unit – ITALY

37th SYMPOSIUM

TOPIC DOPAMINE AND ADDICTION

TITLE

STRUCTURE, REGULATION AND FUNCTION OF THE

DOPAMNIE TRANSPORTER

ORGANIZER NEWMAN H. AMY

National institute on drug abuse/NIH Dept. Of health and Human Service - USA

1st SPEAKER SITTE HARALD

Institute of Pharmacology Center for Physiology and Pharmacology

Medical University Vienna - Austria

2nd SPEAKER ZAHNISER R. NANCY

University of Colorado Denver, Dept. Of Pharmacology school of medicine - USA

3rd SPEAKER JONES SARA

Wake Forest University North Carolina, USA

4th SPEAKER KEITH HENRY

University of North Dakota School of Medicine & Health Sciences, USA.

5th SPEAKER TANDA GIANLUIGI

National Institute on drug Abuse/NIH Dept. Of health and Human Service - Baltimore, USA

38th SYMPOSIUM

TOPIC DOPAMINE AND ADDICTION

TITLE

DIFFERENTIAL ROLE OF THE MESOLIMBIC SYSTEM IN PSYCHOSTIMULANT VERSUS OPIATE REWARD

ORGANIZER ALDO BADIANI

Univ. LA SAPIENZA – Roma

1st SPEAKER DAVID BELIN

INSERM U1084 - Laboratoire de Neurosciences Experimentales et Cliniques (LNEC), FRANCE

2nd SPEAKER TERRY E. ROBINSON

University of Michigan, Ann Arbor, USA

3rd SPEAKER JENNIFER BOSSERT

NIH/NIDA Behavioral Neuroscience Branch

4th SPEAKER ALDO BADIANI

Univ. LA SAPIENZA – Roma

39th SYMPOSIUM

TOPIC DOPAMINE AND COGNITION

TITLE 

MAKING SENSE OF PREFRONTAL CORTICAL

DOPAMINE FUNCTION

ORGANIZER O’DONNEL PATRICIO

University of Maryland School of Medicine Anatomy & Neurobiology, USA

1st SPEAKER FLORESCO STAN

University of British Columbia, Psychology, CANADA

2nd SPEAKER O’DONNEL PATRICIO

University of Maryland School of Medicine Anatomy & Neurobiology, USA

3rd SPEAKER SOHAL VIKAAS

University of California San Francisco, Psychiatry, USA

4th SPEAKER DE BLASI GIUSEPPE

University of Bari, ITALY

40th SYMPOSIUM

TOPIC DOPAMINE AND COGNITION

TITLE

DOPAMINE – RELATED LEARNING DYSFUNCTIONS IN ADDICTION

ORGANIZER HASLER GREGOR

University Hospital Psychiatry - SWITZERLAND

1st SPEAKER TOBLER PHILIPPE

University of Zurich, Psychiatry - SWITZERLAND

2nd SPEAKER FLAGEL SHELLY

University of Michigan, Neurosciences – USA

3rd SPEAKER QUENTIN HUYS

Welcome Trust Centre of Neuroimaging and Gatsby Computational

Neuroscience Unit - UK

4th SPEAKER HASLER GREGOR

University Hospital Psychiatry - SWITZERLAND

41st SYMPOSIUM

TOPIC DOPAMINE AND COGNITION

TITLE

MOLECULAR IMAGING OF DOPAMINE NEUROTRANSMISSION DURING HUMANCOGNITIVE PROCESSING

ORGANIZER BADGAIYAN D. RAJENDRA

SUNY at Buffalo Psychiatry - USA

1st SPEAKER BACKMAN LARS

Karolinska institute Neurobiology – SWEDEN

2nd SPEAKER STRAFELLA ANTONIO

University of Toronto Neurology – CANADA

3rd SPEAKER ZALD DAVID

Vanderbilt University Psychology – USA

4th SPEAKER ZHOU YUN

Johns Hopkins University, Radiology – USA

5th SPEAKER BADGAIYAN D. RAJENDRA

SUNY at Buffalo Psychiatry - USA

42nd SYMPOSIUM

TOPIC DOPAMINE AND COGNITION

TITLE

NOVELTIES OF DOPAMINERGIC SYSTEM IN ADHD

SYMPTOMATOLOGY AND TREATMENT

ORGANIZER KOSTRZEW M. RICHARD

East Tennessee state University Quillen College of Medicine Biomedical Sciences –USA

1st SPEAKER FLECKENSTEIN E. ANNETTE

University of Utah Pharmacology and toxicology - USA

2nd SPEAKER KOSTRZEW M. RICHARD

East Tennessee State University, Quillen College of Medicine, Biomedical Sciences- USA

3rd SPEAKER HESS J. ELLEN

Emory University, School of Medicine Pharmacology and Neurology - USA

4th SPEAKER TARAZI I. FRANK

MCLEAN Hospital, Harvard Medical School Laboratory of Psychiatry Neuroscience - USA

5th SPEAKER ARCHER TREVOR

University of Gothenburg - SWEDEN

43rd SYMPOSIUM

TOPIC DOPAMINE AND AFFECTIVE DISORDERS

TITLE

ALTERING ADULT BRAIN FUNCTION: ENDURING EFFECTS OF EARLY-LIFE STIMULANT EXPOSURE

ORGANIZER STEINER HEINZ

Rosalind Franklin University of Medicine and Science The Chicago Medical School Cellular and Molecular Pharmacology, USA

1st SPEAKER KOSOFSKY BARRY

Weill-Cornell Medical College Molecular and Developmental Neuroscience, NY, USA

2nd SPEAKER BHIDE PRADEEP

Florida State University College of Medicine Biomedical Sciences, USA

3rd SPEAKER STEINER HEINZ

Rosalind Franklin University of Medicine and Science, The Chicago

Medical School, USA.

4th SPEAKER BOLANOS CARLOS

Florida State University, Psychology Department, USA

44th SYMPOSIUM

TOPIC DOPAMINE AND AFFECTIVE DISORDERS

TITLE

THE ROLE OF THE DOPAMINE TRANSPORTER IN

HUMAN DISEASE

ORGANIZER KURIAN MANJU

University College London (UCL) ICH- Neurosciences Unit, UK

1st SPEAKER REITH MAARTEN

New York University Department of Psychiatry and Pharmacol. USA

2nd SPEAKER BLAKELY RANDY

Vanderbilt University, Centre for Molecular Neuroscience, USA

3rd SPEAKER GALLI AURELIO

Vanderbilt University, Centre for Molecular Neuroscience, USA

4th SPEAKER KURIAN MANJU

University College London (UCL), ICH- Neurosciences Unit, UK

45th SYMPOSIUM

TOPIC DOPAMINE AND NEURODEGENERATION

TITLE

A-SYNUCLEIN INDUCED TOXICITY: SYNAPTIC DYSFUNCTION AND NEURODEGENERATION INDOPAMINE NEURONS

ORGANIZER BJORKLUND ANDERS

Lund Universit, Wallenberg Neuroscience Center, Lund, SWEDEN

1st SPEAKER RUBINSTEIN DAVID

University of Cambridge,Cambridge Institute for Medical Research

Department of Medical Genetics, UK

2nd SPEAKER OUTEIRO TIAGO

University of Lisbon, PORTUGAL

3rd SPEAKER SPANO PIERFRANCO

School of Medicine, University of Brescia, Brescia, ITALY

4th SPEAKER BJORKLUND ANDERS

Lund University, Wallenberg Neuroscience center, Lund, SWEDEN

46th SYMPOSIUM

TOPIC DOPAMINE AND NEURODEGENERATION

TITLE 

ALTERED ROLE OF DOPAMINE IN HUNTINGTON’S

DISEASE

ORGANIZER LEVINE MICHAEL

Intellectual and developmental disabilities research centre - USA

1st SPEAKER PARENT MARTIN

University of Laval CRIUSMQ – CANADA

2nd SPEAKER MURPHY KERRY

The Open University Depart. Of Life Sciences - UK

3rd SPEAKER CEPEDA CARLOS

Intellectual and Developmental disabilities Research Center - USA

4th SPEAKER ABERCROMBIE ELIZABETH

Rutgers University Center for Molecular and Behavioral Neuroscience, Newark, USA

47th SYMPOSIUM

TOPIC DOPAMINE AND PARKINSON’S DISEASE

TITLE

TRANSCRIPTION FACTORS AS MEDIATORS OF DOPAMINE NEURODEGENERATION IN PARKINSON'S DISEASE

ORGANIZER DECRESSAC MICKAEL

Lund University Wallenberg Neuroscience Center, Lund, SWEDEN

1st SPEAKER PERLMANN THOMAS

Karolinska Institute Ludwing Institute for Cancer Research ltd.

Departmente of Cell and Molecular biology, SWEDEN

2nd SPEAKER PROCHIANTZ ALAIN

College de France, Ecole Normale Superieure, Paris, FRANCE

3rd° SPEAKER DECRESSAC MICKAEL

Lund University Wallenberg Neuroscience Center, Lund, SWEDEN

4th SPEAKER JANKOVIC JOSEPH

Baylor College of Medicine Parkinson’s Diseas center and movement

Disorders clinic, USA

48th SYMPOSIUM

TOPIC DOPAMINE AND PARKINSON’S DISEASE

TITLE

NEURORESTORATION

ORGANIZER YOUDIM B.H. MOUSSA

Technion – Faculty of Medicine Eve Topf Center of Excellence For

Neurodegenerative diseases, ISRAEL

1st SPEAKER ZIGMOND MICHAEL

Pitsburgh University, Dept. Of Neuroscience, USA

2nd SPEAKER YOUDIM B.H. MOUSSA

Technion – Faculty of Medicine Eve Topf Center of Excellence For

Neurodegenerative diseases, ISRAEL

3rd SPEAKER LINDAVALL OLLE

University Hospital Wallenberg Neuroscience Center, Lund, SWEDEN

4th SPEAKER MELAMED ELDAD

Tel Aviv University, Neurology, ISRAEL

49th SYMPOSIUM

TOPIC DOPAMINE AND PARKINSON’S DISEASE

TITLE

ORGANIZER PAUL TUITE

Dept. of Neurology, University of Minnesota, Minneapolis, USA

1st SPEAKER MARTIN J MCKEOWN

University of British Columbia, Vancouver, CANADA

2nd SPEAKER OZ GULIN

University of Minnesota, Center for MR Research Radiology, USA

3rd SPEAKER MICHAELI SHALOM

University of Minnesota, CMRR Radiology, USA

4th SPEAKER NICOLAAS BOHNEN

University of Michigan, Ann Arbor, USA

5th SPEAKER CHO ZANG HEE

Neuroscience Research Institute, Gachon University of Medicine and Science, Incheon, KOREA

50th SYMPOSIUM

TOPIC DOPAMINE AND PARKINSON’S DISEASE

TITLE 

NEURODEGENERATIVE MECHANISM OF PARKINSON’S DISEASE AND POTENTIAL NEUROPROTECTIVE STRATEGIES

ORGANIZER LUIGI ZECCA

National Research Council of Italy Institute of Biomedical Technologies - ITALY

1st SPEAKER MORELLI MICAELA

University of Cagliari,Department of biomedical Sciences - ITALY

2nd SPEAKER PIZZI MARINA

University of Brescia, Department of Melecular and translational

medicine, ITALY

3rd SPEAKER SULZER DAVID

Columbia university Department of Neurology - USA

4th SPEAKER LUIGI ZECCA

National Research Council of Italy Institute of Biomedical Technologies - ITALY

51st SYMPOSIUM

TOPIC DOPAMINE AND PARKINSON’S DISEASE

TITLE 

FUNCTIONAL INTEGRATION OF STEM CELL-DERIVED

DOPAMINERGIC GRAFTS IN EXPERIMENTAL

PARKINSON'S DISEASE

 

ORGANIZER KOKAIA MERAB

Lund University Clinical Sciences - SWEDEN

1st SPEAKER LI MENG

IMPERIAL COLLEGE London, UK

2nd SPEAKER WEICH P. JASON

Univ of Wisconsin – Madison, Waisman Center - USA

3rd SPEAKER BRUSTLE OLIVER

University of Bonn, Institute of Reconstructive Neurobiology

- GERMANY

4th SPEAKER TONNESEN JAN

LUND UNIVERSITY, CLINICAL SCIENCES - SWEDEN

52nd SYMPOSIUM

TOPIC DOPAMINE AND PARKINSON’S DISEASE

TITLE 

PRE-SYNAPTIC AND POST-SYNAPTIC MECHANISM IN L-DOPA-INDUCED DYSKINESIA

ORGANIZER CARTA MANOLO

Univ of Cagliari, Dept. of Biomed. Sci. ITALY

1st SPEAKER CENCI ANGELA

Lund University Experimental Medical Science - SWEDEN

2nd SPEAKER PICCINI PAOLA

Imperial College London Medicine – UK

3rd SPEAKER BEZARD ERWAN

Institute des Maladies Neurod.- FRANCE

4th SPEAKER CALABRESI PAOLO

Perugia University Specialit. Medico Chirurgiche e Sanit. Pubblica

ITALY

53rd SYMPOSIUM

TOPIC DOPAMINE AND PARKINSON’S DISEASE

TITLE

NEW MODELS OF NEURODEGENERATION FOR EXPERIMENTAL PARKINSON’S DISEASE

ORGANIZER BLANDINI FABIO

IRCCS National Neurological Institute C. Mondino Interdepartmental Research Centre for Parkinson’s disease- ITALY

1st SPEAKER DI MONTE DONATO

German Centre for neurodegenerative Disease (DZNE) - GERMANY

2nd SPEAKER CARTA ANNA

University of Cagliari Dept. of Biomedical Science – ITALY

3rd SPEAKER SPILLANTINI MARIA GRAZIA

University of Cambridge, Dept Clinical Neurosciences, UK

4th SPEAKER BLANDINI FABIO

IRCCS National Neurological Institute C. Mondino Interdepartmental Research Centre for Parkinosn’s disease- ITALY

54th SYMPOSIUM

TOPIC DOPAMINE AND PARKINSON’S DISEASE

TITLE

DOPAMINE AND RESTLESS LEGS SYNDROME

ORGANIZER PAULUS WALTER

Clinical Neurophysiology –GERMANY

1st SPEAKER TRENKWALDER CLAUDIA

Paracelsus Elena Klinik Movemente Disorders Klinik - GERMANY

2nd SPEAKER PAULUS WALTER

University of Gottingen Clinical Neurophysiology –GERMANY

3rd SPEAKER RYE DAVID

Emory University Emory Programm in sleep –GERMANY

4th SPEAKER GHORAYEB IMAN

UNIV. Victor segalen Bordeaux Institut des Maldies Neurodegeneratives- FRANCE

55th SYMPOSIUM

TOPIC DOPAMINE AND PARKINSON’S DISEASE

TITLE 

IMPULSIVITY IN PARKINSON’S DISEASE

ORGANIZER AVERBECK BRUNO

National Institute of Mental Health Laboratory of Neuropsychology - USA

1st SPEAKER DJAMSHIDIAN ATBIN

University College London Reta Lila Weston Institute for Neurological Studies-UK

2nd SPEAKER VOON VALERIE 

Cambridge Psychiatry - UK

3rd SPEAKER RAY NICOLA

UNIVERSITY OF TORONTO, CANADA

4th SPEAKER ROWE JAMES

CAMBRIDGE UNIVERSITY, UK

56th° SYMPOSIUM

TOPIC DOPAMINE AND PARKINSON’S DISEASE

TITLE

NEUROINFLAMMATION AND ADAPTIVE

IMMUNITY IN PARKINSON’S DISEASE NEUROPATHOLOGY

ORGANIZER CARTA R. ANNA

University of Cagliari, Biomedical science - ITALY

1st SPEAKER PITOSSI FERNANDO

Fundacion Instituto Leloir Regenerative and protective therapies of the CNS - ARGENTINA

2nd SPEAKER GUNTER U. HOGLINGER

University of Cagliari Biomedical science - ITALY

3rd SPEAKER HERRERO MARIA TRINIDAD

University of Murcia, Human Anatomy & psychobiology - SPAIN

4th SPEAKER HUNOT STEPHANE

Inserm Brain & Spine Institute Research Center - France

57° SYMPOSIUM

TOPIC DOPAMINE AND SCHIZOPHRENIA

TITLE

DA RECEPTORS AND THEIR INTERACTIONS WITH

OTHER MONOAMINE RECEPTOR MECHANISMS

REMAIN A TARGET FOR TREATMENT OF

SCHIZOPHRENIA

ORGANIZER FUXE KJELL

Karolinska Institutet, Stockholm, SWEDEN

1st SPEAKER ARVID CARLSSON

Gothenburg University, SWEDEN

2nd SPEAKER AGNATI LUIGI

University of Modena, Biomedical sciences, ITALY

3rd SPEAKER FUXE KJELL

Karolinska Institutet, Neuroscience, Stockholm, SWEDEN

4th SPEAKER TANGANELLI SERGIO

University of Ferrara, Clinical and Experimental Medicine, ITALY

58th SYMPOSIUM

TOPIC DOPAMINE AND SCHIZOPHRENIA

TITLE

HIPPOCAMPAL OVERDRIVE OF THE MESOSTRIATAL DOPAMINE SYSTEM AS A BASIS FOR PSYCHOSIS IN SCHIZOPHRENIA

ORGANIZER GRACE A. ANTHONY

University of Pittsburgh Neuroscience Psychiatry and Physiology, USA

1st SPEAKER LODGE DANIEL

University of Texas Health Sciences Center San Antonio-USA

2nd SPEAKER HOWES OLIVER

Institute of Psychiatry, Clinical Science Center and Psychosis Studies, UK

3rd SPEAKER ABI-DARGHAM ANISSA

Columbia college of Physicians and Surgeons Translational Imaging, NY, USA

4th SPEAKER DUEZEL EMRAH

University of Magdeburg Institute of Cognitive Neurology and Dementia Research, GERMANY

59th SYMPOSIUM

TOPIC DOPAMINE AND SCHIZOPHRENIA

TITLE

DOPAMINERGIC FUNCTION IN MICE MUTANT FOR

SCHIZOPHRENIA-RELATED GENES: CONVERGENCE OR

DIVERGENCE?

ORGANIZER WADDINGTON L. JOHN

Royal College of Surgeons in Ireland Molecular & Cellular Therapeutics, Dublin, IRELAND

1st SPEAKER PAPALEO FRANCESCO

Istituto Italiano di Tecnologia Neuroscience and brain Technologies, Genova, ITALY

2nd SPEAKER LIPINA TATIANA

Mount Sinai Hospital Samuel Lunenfeld Research Institute, NY, USA

3rd SPEAKER NAWA HIROYUKI

Niigata University Brain Research Institute Neurobiology, JAPAN

4th SPEAKER O’TUATHAIGH M. COLM

University College Cork School of Medicine, IRELAND

60th SYMPOSIUM

TOPIC DOPAMINE AND SCHIZOPHRENIA

TITLE

DOPAMINE-GLUTAMATE INTERACTIONS IN BRAIN AND THE TREATMENT OF SCHIZOPHRENIA

ORGANIZER SOKOLOFF PIERRE

Pierre Fabre Research Institute Neurology - Psychiatry - FRANCE

1st SPEAKER KUEI TSENG

RFUMS/Chicago Medical School, USA

2nd SPEAKER CASTNER A. STACY

Yale School of Medicine Psychiatry - USA

3rd SPEAKER SVENSSON H. TORGNY

Karolinska Institutet Department of Physiology and Pharmacology

- SWEDEN

4th SPEAKER SOKOLOFF PIERRE

Pierre Fabre Research Institute Neurology - Psychiatry - FRANCE

5th SPEAKER MOGHADDAM BITA

University of Pittsburg Dept. of neuroscience -USA

 

 

Share 0
Like 0